In this article, we will discuss: 12 Best Marijuana Stocks to Buy According to Analysts.
Marijuana stocks, frequently known as cannabis stocks, are publicly traded firms that operate in the legal cannabis market. This can include any company participating in the supply chain, from plant cultivation and processing to distribution and sale of cannabis and related goods.
The US administration is looking into reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act, a move that may substantially alter the marijuana industry. Currently, marijuana is classified as having a high potential for abuse and no recognized medical use under Schedule I, which bars businesses from using standard banking and exposes them to Section 280E of the federal tax code, which prohibits business deductions. The removal of 280E limits by reclassification would cut effective tax rates, increase profitability, and provide access to institutional investors and lower-cost investments. The announcement caused U.S.-listed cannabis-related stocks to soar. However, analysts point out that reclassification does not imply legalization.
According to TD Cowen analyst Jaret Seiberg:
“It seems more likely to us that Trump would revive the effort at the DEA to move cannabis to Schedule III, which would permit the government to regulate it.”
With that said, here are the 12 Best Marijuana Stocks to Buy According to Analysts.
kostrez/Shutterstock.com
Our Methodology
For this article, we compiled an initial list of 15 marijuana stocks. Then we selected the 12 stocks that had the highest upside potential as of September 5, 2025. We have only included stocks in our list with an upside potential of 4% or higher. The stocks are ranked in ascending order of upside potential.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
12. Aurora Cannabis Inc. (NASDAQ:ACB)
Analysts’ Upside Potential as of September 5: 4.55%
Aurora Cannabis Inc. (NASDAQ:ACB) and German healthcare technology company Copeia have released an English-language version of the Physician Experience Platform (PEP). The platform has over 130 anonymized case studies detailing real-world medicinal cannabis treatments, including patient history, symptoms, dose, outcomes, and concurrent medicines. PEP, which is initially available in Canada, the United Kingdom, Poland, Malta, the Czech Republic, Australia, and New Zealand, intends to provide healthcare professionals with access to peer-reviewed clinical insights. Aurora Cannabis Inc. (NASDAQ:ACB)’s Director of Medical & Patient Affairs, Dr. Stephanie Lunn, stated that the launch “sets a new standard in peer-led clinical knowledge sharing.”
PEP builds on the successful German launch in 2024 and is protected by a DocCheck login for verified physicians. The firm intends to create an international medical cannabis case study database that will enable physicians from around the world to upload cases in the future. Aurora Cannabis Inc. (NASDAQ:ACB) operates in the global medicinal and consumer cannabis markets under names such as MedReleaf, CanniMed, Drift, and San Rafael ’71. It is one of the Best Marijuana Stocks.
11. Turning Point Brands, Inc. (NYSE:TPB)
Analysts’ Upside Potential as of September 5: 5.47%
Turning Point Brands, Inc. (NYSE:TPB) confirmed the launch of Stoker’s Fine Cut Wintergreen in a compact 1.2-ounce can in 15 states. The Fine Cut Wintergreen, which was previously only available in 12-ounce tubs, offers the same silky, fire-cured tobacco flavor and moisture content in a portable form. Senior Brand Director Thomas Helms III stated, “Our consumers have been asking for a Fine Cut Wintergreen can — and we listened,” adding that the launch improves Stoker’s moist smokeless tobacco (MST) line and gives retailers new growth possibilities. According to internal research, MST sales are three to five times greater in retailers that stock both cans and tubs.
Stoker’s is the No. 2 chewing tobacco brand and a rapidly expanding brand in the MST area. The launch facilitates national distribution and category extension, with availability scheduled for both independent and chain retailers in 2025. Stoker’s® is manufactured and marketed by Turning Point Brands, Inc. (NYSE:TPB), a prominent manufacturer, marketer, and distributor of branded consumer products. It is among the Best Marijuana Stocks.
10. The Scotts Miracle-Gro Company (NYSE:SMG)
Analysts’ Upside Potential as of September 5: 12.90%
The Scotts Miracle-Gro Company (NYSE:SMG) made major strides toward sustainability and ESG targets in its 2025 Corporate Responsibility Report. Key accomplishments for the company included diverting 1.76 million pounds of coir waste for industrial and agricultural use, reducing virgin plastic with Ortho brand reusable pouches, and achieving 100% recyclable packaging for its O.M. Scott & Sons brand. The amount of water used for greenhouse irrigation was reduced by over 50%. The company also reached over 157 million people through partnership programs that promote water quality and land conservation.
Jim Hagedorn, the firm’s chairman and CEO, highlighted the company’s goal to “GroMoreGood” by harmonizing its goods with environmental responsibility. The Scotts Miracle-Gro Company (NYSE:SMG) introduced Miracle-Gro Organic Raised Bed & Garden Soil in 2024, and in 2025, it added both indoor and outdoor organic products to its portfolio. The company has continued to support community efforts. It has provided over 180 grants for garden and green space education programs, including partnerships with The Nature Conservancy and Columbus City Schools. It is ranked tenth on our list of the Best Marijuana Stocks.
Hedge Fund Resource Center